Herpes simplex virus 1 interaction with myeloid cells in vivo

Journal of Virology

Volumn 90, Issue 19, 2016, Pages 8661-8672

  Shivkumar, Maitreyi ^a,c   Lawler, Clara ^b   Milho, Ricardo ^a,d   Stevenson, Philip G ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Department of Health Economics and Statistics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; INTERFERON;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TITRATION; VIRUS TRANSMISSION; ANIMAL; C57BL MOUSE; CELL CULTURE; PHYSIOLOGY; VIRAL TROPISM; VIROLOGY;

ANIMALS; CELLS, CULTURED; HERPESVIRUS 1, HUMAN; MICE, INBRED C57BL; MYELOID CELLS; VIRAL TROPISM;

EID: 84990191395     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00881-16     Document Type: Article

References (54)

1. Fenner F, White DO. 1994. Medical virology, 4th ed. Academic Press, London, United Kingdom
2. McGeoch DJ, Rixon FJ, Davison AJ. 2006. Topics in herpesvirus genomics and evolution. Virus Res 117:90-104. http://dx.doi.org/10.1016/j.virusres.2006.01.002
3. Milho R, Frederico B, Efstathiou S, Stevenson PG. 2012. A heparandependent herpesvirus targets the olfactory neuroepithelium for host entry. PLoS Pathog 8:e1002986. http://dx.doi.org/10.1371/journal.ppat.1002986
4. Farrell HE, Lawler C, Tan CS, MacDonald K, Bruce K, Mach M, Davis-Poynter N, Stevenson PG. 2016. Murine cytomegalovirus exploits olfaction to enter new hosts. mBio 7:e00251-16. http://dx.doi.org/10.1128/mBio.00251-16
5. Shivkumar M, Milho R, May JS, Nicoll MP, Efstathiou S, Stevenson PG. 2013. Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry. J Virol 87:10477-10488. http://dx.doi.org/10.1128/JVI.01748-13
6. Gaspar M, May JS, Sukla S, Frederico B, Gill MB, Smith CM, Belz GT, Stevenson PG. 2011. Murid herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathog 7:e1002346. http://dx.doi.org/10.1371/journal.ppat.1002346
7. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, Mocarski ES. 1994. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 68:6243-6253
8. Brautigam AR, Dutko FJ, Olding LB, Oldstone MB. 1979. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J Gen Virol 44: 349-359. http://dx.doi.org/10.1099/0022-1317-44-2-349
9. Frederico B, Milho R, May JS, Gillet L, Stevenson PG. 2012. Myeloid infection links epithelial and B cell tropisms of murid herpesvirus-4. PLoS Pathog 8:e1002935. http://dx.doi.org/10.1371/journal.ppat.1002935
10. Linnavuori K, Hovi T. 1981. Herpes simplex virus infection in human monocyte cultures: dose-dependent inhibition of monocyte differentiation resulting in abortive infection. J Gen Virol 52:381-385. http://dx.doi.org/10.1099/0022-1317-52-2-381
11. Stevens JG, Cook ML. 1971. Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction. J Exp Med 133:19-38
12. Lopez C, Dudas G. 1979. Replication of herpes simplex virus type 1 in macrophages from resistant and susceptible mice. Infect Immun 23:432-437
13. Kobelt D, Lechmann M, Steinkasserer A. 2003. The interaction between dendritic cells and herpes simplex virus-1. Curr Top Microbiol Immunol 276:145-161
14. Jones CA, Fernandez M, Herc K, Bosnjak L, Miranda-Saksena M, Boadle RA, Cunningham A. 2003. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J Virol 77:11139-11149. http://dx.doi.org/10.1128/JVI.77.20.11139-11149.2003
15. Taylor-Wiedeman J, Sissons P, Sinclair J. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 68:1597-1604
16. Weck KE, Kim SS, Virgin HW, Speck SH. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol 73:3273-3283
17. Rosa GT, Gillet L, Smith CM, de Lima BD, Stevenson PG. 2007. IgG fc receptors provide an alternative infection route for murine gammaherpesvirus-68. PLoS One 2:e560. http://dx.doi.org/10.1371/journal.pone.0000560
18. Salio M, Cella M, Suter M, Lanzavecchia A. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 29:3245-3253
19. Samady L, Costigliola E, MacCormac L, McGrath Y, Cleverley S, Lilley CE, Smith J, Latchman DS, Chain B, Coffin RS. 2003. Deletion of the virion host shutoffprotein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs-HSV vectors for dendritic cell-mediated immunotherapy. J Virol 77:3768-3776. http://dx.doi.org/10.1128/JVI.77.6.3768-3776.2003
20. Smith CM, Gill MB, May JS, Stevenson PG. 2007. Murine gammaherpesvirus-68 inhibits antigen presentation by dendritic cells. PLoS One 2:e1048. http://dx.doi.org/10.1371/journal.pone.0001048
21. Mount AM, Masson F, Kupresanin F, Smith CM, May JS, van Rooijen N, Stevenson PG, Belz GT. 2010. Interference with dendritic cell populations limits early antigen presentation in chronic γ-herpesvirus-68 infection. J Immunol 185:3669-3676. http://dx.doi.org/10.4049/jimmunol.1001079
22. Zisman B, Hirsch MS, Allison AC. 1970. Selective effects of antimacrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol 104:1155-1159
23. Kassim SH, Rajasagi NK, Zhao X, Chervenak R, Jennings SR. 2006. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol 80:3985-3993. http://dx.doi.org/10.1128/JVI.80.8.3985-3993.2006
24. Linnavuori K, Hovi T. 1983. Restricted replication of herpes simplex virus in human monocyte cultures: role of interferon. Virology 130:1-9. http://dx.doi.org/10.1016/0042-6822(83)90112-5
25. Domke I, Straub P, Kirchner H. 1986. Effect of interferon on replication of herpes simplex virus types 1 and 2 in human macrophages. J Virol 60:37-42
26. Brücher J, Domke I, Schröder CH, Kirchner H. 1984. Experimental infection of inbred mice with herpes simplex virus VI: effect of interferon on in vitro replication in macrophages. Arch Virol 82:83-93. http://dx.doi.org/10.1007/BF01309370
27. Caton ML, Smith-Raska MR, Reizis B. 2007. Notch-RBP-J signaling controls the homeostasis of CD8+ dendritic cells in the spleen. J Exp Med 204:1653-1664. http://dx.doi.org/10.1084/jem.20062648
28. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8:265-277. http://dx.doi.org/10.1023/A:1008942828960
29. Tan CS, Frederico B, Stevenson PG. 2014. Herpesvirus delivery to the murine respiratory tract. J Virol Methods 206:105-114. http://dx.doi.org/10.1016/j.jviromet.2014.06.003
30. Stevenson PG, May JS, Smith XG, Marques S, Adler H, Koszinowski UH, Simas JP, Efstathiou S. 2002. K3-mediated evasion of CD8+ T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3:733-740
31. Hill TJ, Field HJ, Blyth WA. 1975. Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J Gen Virol 28:341-353. http://dx.doi.org/10.1099/0022-1317-28-3-341
32. Proença JT, Coleman HM, Connor V, Winton DJ, Efstathiou S. 2008. A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones. J Gen Virol 89: 2965-2974. http://dx.doi.org/10.1099/vir.0.2008/005066-0
33. Zenner HL, Yoshimura S, Barr FA, Crump CM. 2011. Analysis of Rab GTPase-activating proteins indicates that Rab1a/b and Rab43 are important for herpes simplex virus 1 secondary envelopment. J Virol 85:8012-8021. http://dx.doi.org/10.1128/JVI.00500-11
34. McLean C, Buckmaster A, Hancock D, Buchan A, Fuller A, Minson A. 1982. Monoclonal antibodies to three non-glycosylated antigens of herpes simplex virus type 2. J Gen Virol 63:297-305. http://dx.doi.org/10.1099/0022-1317-63-2-297
35. Field HJ, Darby G, Wildy P. 1980. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol 49:115-124. http://dx.doi.org/10.1099/0022-1317-49-1-115
36. Farrell HE, McLean CS, Harley C, Efstathiou S, Inglis S, Minson AC. 1994. Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J Virol 68:927-932
37. Balan P, Davis-Poynter N, Bell S, Atkinson H, Browne H, Minson T. 1994. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J Gen Virol 75:1245-1258. http://dx.doi.org/10.1099/0022-1317-75-6-1245
38. Frederico B, Chao B, May JS, Belz GT, Stevenson PG. 2014. A murid gamma-herpesviruses exploits normal splenic immune communication routes for systemic spread. Cell Host Microbe 15:457-470. http://dx.doi.org/10.1016/j.chom.2014.03.010
39. Frederico B, Chao B, Lawler C, May JS, Stevenson PG. 2015. Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination. J Gen Virol 96:2314-2327. http://dx.doi.org/10.1099/vir.0.000140
40. Lawler C, Milho R, May JS, Stevenson PG. 2015. Rhadinovirus host entry by co-operative infection. PLoS Pathog 11:e1004761. http://dx.doi.org/10.1371/journal.ppat.1004761
41. Farrell HE, Lawler C, Oliveira MT, Davis-Poynter N, Stevenson PG. 2016. Alveolar macrophages are a prominent but nonessential target for murine cytomegalovirus infecting the lungs. J Virol 90:2756-2766. http://dx.doi.org/10.1128/JVI.02856-15
42. Hume DA. 2011. Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity. J Leukoc Biol 89:525-538. http://dx.doi.org/10.1189/jlb.0810472
43. Farrell HE, Davis-Poynter N, Bruce K, Lawler C, Dolken L, Mach M, Stevenson PG. 2015. Lymph node macrophages restrict murine cytomegalovirus dissemination. J Virol 89:7147-7158. http://dx.doi.org/10.1128/JVI.00480-15
44. Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL. 2011. Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol 1:487-496. http://dx.doi.org/10.1016/j.coviro.2011.10.016
45. Luker GD, Prior JL, Song J, Pica CM, Leib DA. 2003. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol 77:11082-11093. http://dx.doi.org/10.1128/JVI.77.20.11082-11093.2003
46. Rosato PC, Leib DA. 2015. Neuronal interferon signaling is required for protection against herpes simplex virus replication and pathogenesis. PLoS Pathog 11:e1005028. http://dx.doi.org/10.1371/journal.ppat.1005028
47. Sandberg K, Eloranta ML, Campbell IL. 1994. Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/betainduced genes in lymphocytic choriomeningitis. J Virol 68:7358-7366
48. Gray EE, Cyster JG. 2012. Lymph node macrophages. J Innate Immun 4:424-436. http://dx.doi.org/10.1159/000337007
49. Garcia Z, Lemaître F, van Rooijen N, Albert ML, Levy Y, Schwartz O, Bousso P. 2012. Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles. Blood 120:4744-4750. http://dx.doi.org/10.1182/blood-2012-02-408179
50. Anderson AO, Shaw S. 1993. T cell adhesion to endothelium: the FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node. Semin Immunol 5:271-282. http://dx.doi.org/10.1006/smim.1993.1031
51. Kuka M, Iannacone M. 2014. The role of lymph node sinus macrophages in host defense. Ann N Y Acad Sci 1319:38-46. http://dx.doi.org/10.1111/nyas.12387
52. Paladino P, Mossman KL. 2009. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J Interferon Cytokine Res 29:599-607. http://dx.doi.org/10.1089/jir.2009.0074
53. Mattei F, Schiavoni G, Tough DF. 2010. Regulation of immune cell homeostasis by type I interferons. Cytokine Growth Factor Rev 21:227-236. http://dx.doi.org/10.1016/j.cytogfr.2010.05.002
54. Reyes-Vázquez C, Prieto-Gómez B, Dafny N. 2012. Interferon modulates central nervous system function. Brain Res 1442:76-89. http://dx.doi.org/10.1016/j.brainres.2011.09.061.